Masimo Corporation receives the highest value in the Current-Impact Index of the ipIQ Medical Devices Patent Scorecard™ for 2006. The Current-Impact Index showcases the broader significance of a company’s patents by examining how often its U.S. patents are used as the basis for other innovation in the current year. A value of 140 indicates a company’s patents were referenced 40% more often than the industry average. Masimo achieved a score of 1,294 for the year 2005. In addition, the company also topped the Technology Cycle Time™ category, which indicates a firm’s speed in turning proprietary research and innovations into Intellectual Property.
The Patent Scorecard is an industry-by-industry ranking of corporate innovation and combines a series of indicators to arrive at patent quality, technological strength and breadth of impact. It has historically been published in MIT’s Technology Review and tracks the U.S. patent portfolio of more than 2,500 of the world’s top technology firms.
To view the full award, please click here .
